ArticleCells2022

MYH9 Facilitates Cell Invasion and Radioresistance in Head and Neck Cancer via Modulation of Cellular ROS Levels by Activating the MAPK-Nrf2-GCLC Pathway.

Guo-Rung You et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.